PITTSBURGH, Pa. – UPMC announced a bold plan to transform patient care with three leading-edge, new specialty hospitals that will offer next-generation treatments in patient-focused, technology-enhanced settings unique to healthcare. Backed by a $2-billion investment from UPMC, the all-new UPMC Heart and Transplant Hospital, UPMC Hillman Cancer Hospital and UPMC Vision and Rehabilitation Hospital will add to UPMC’s complement of advanced specialty care at Magee-Womens Hospital, Western Psychiatric Institute and Clinic and Children’s Hospital of Pittsburgh (Pennsylvania).
The all-new hospitals will be situated on the campuses of UPMC’s Mercy, Presbyterian and Shadyside hospitals. Designs for the UPMC Heart and Transplant Hospital and the UPMC Hillman Cancer Hospital will be selected in an international design competition.
The UPMC Vision and Rehabilitation Hospital, on the UPMC Mercy campus, is expected to open in 2020 to offer advanced clinical vision care. Clinicians and researchers at the new hospital will pursue promising new research for vision restoration and diseases of the eye, and offer technology-assisted rehabilitation services that restore mobility for patients with wide-ranging physical and cognitive challenges.
Patients of the UPMC Hillman Cancer Center will receive specialized treatment in the new UPMC Hillman Cancer Hospital, located on the UPMC Shadyside campus. The facility is expected to open in 2022.
Building on UPMC’s legacy in organ transplantation, the UPMC Heart and Transplant Hospital in the heart of Oakland on the UPMC Presbyterian campus will provide the highest caliber organ transplantation and cardiac procedures available anywhere in the world.
